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Summary Desmosomes are intercellular junctions that have been shown to be down-regulated in certain types of carcinoma and that may
play a role in suppression of invasion and metastasis. This paper describes an immunohistochemical study of three types of epidermal
neoplasms with monoclonal antibody to desmoglein in orderto determine how desmosomal staining correlates with the clinical, biological and
histopathological features of these neoplasms. Actinic keratosis (AK) is the most common keratinocytic premalignant neoplasm that was
reported to have a 10-20% rate of malignant transformation into squamous cell carcinoma (SCC). Keratoacanthoma (KA) is a benign
neoplasm that involutes spontaneously after a few months of rapid growth. SCC is a malignant tumour capable of metastasis. Electron
microscope studies of KA and SCC showed significantly reduced staining for desmosomes in SCC but not in KA. We have examined staining
for desmoglein using the monoclonal antibody 33-3D, a mouse IgM monoclonal antibody, that recognizes the cytoplasmic domains of
desmoglein (Dsg)1 and Dsg2 on frozen sections. Immunohistochemical staining of normal skin with this antibody revealed strong pericellular
localization of the antigen, outlining the cell membranes of the keratinocytes. A series of 30 AKs, 12 KAs and 24 SCCs was stained
immunohistochemically with 33-3D monoclonal antibody. All examined KAs showed extensive pericellular staining for Dsg. By contrast,
juxtanuclear staining for Dsg was noted in 12 SCCs, and completely negative staining in seven SCCs. The five remaining SCCs showed focal
pericellular staining for the Dsg marker. The most common finding in AK was focal pericellular staining for Dsg, with complete absence of
staining in dysplastic areas (25 cases). In five cases negative pericellular staining in dysplastic areas was associated with juxtanuclear
accumulation of the Dsg marker. A strong negative correlation between Dsg staining and degree of dysplasia was obtained. The Dsg pattern
in KA is similar to normal epidermis and shows a clear difference between KA and SCC. AK has a limited loss of Dsg expression in a SCC-
like pattern that is congruent with its premalignant nature. As the stain works on frozen tissue, it may be helpful for rapid differentiation in
selected cases in cutaneous oncology and Mohs micrographic surgery. This antibody may also have great potential for the detection of the
effects of chemopreventive agents in skin cancer.
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Keratinocyte-derived skin tumours with squamous phenotype
belong to the group of the most common human neoplasms
(Weinstock, 1994), actinic keratosis (AK), squamous cell carci-
noma (SCC) and keratoacanthoma (KA) being the most prevalent
types (Schwartz, 1996; Weinstock, 1994). AKs are sun-induced,
small, red, scaly plaques characterized by focal epidermal
dysplasia. They are considered premalignant as they may develop
into invasive SCC. The transformation rate has been calculated to
be around 12-13%, or even as high as 20%, especially after
repeated sun exposure (Schwartz, 1996). SCC is malignant
keratinocytic tumour that is both invasive and capable of metas-
tasis (Kwa et al, 1992). KA is akeratinizing crateriform neoplasm,
classically occurring on the ultraviolet radiation (UVR)-exposed
skin of elderly individuals (Schwartz, 1994). Clinically, it is
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characterized by aperiod ofrapid growth followed by spontaneous
regression. Histologically KA resembles SCC and, although
histopathological differentiation may sometimes be difficult, the
biologically benign course ofKA allows clear distinction from the
latter (Schwartz, 1994). Many immunohistochemical studies have
claimed to be helpful in the distinction between KA and SCC.
However, until very recently, the results have been conflicting and
lead to the opinion that KA is a variant ofSCC (Hodak et al, 1993;
Schwartz, 1994; Cain et al, 1995). Our most recent results show
that immunohistochemical staining for desmoglein (Dsg) appears
to distinguish clearly between KA and SCC (Krunic et al, 1996).
Desmosomes are intercellularjunctions that have been shown to
be down-regulated in certain types of carcinoma (reviewed by
Garrod, 1993, 1996; Hiraki et al, 1996). They may play a role in
suppression of invasion and metastasis as altered cell-cell adhe-
sion makes an important contribution to both of these processes
(Hiraki et al, 1996). Dsgs are transmembrane desmosomal glyco-
proteins that exist in three isoforms. Desmoglein 1 (Dsgl) and
Dsg3 have recently been characterized as pemphigus foliaceus and
pemphigus vulgaris antigen respectively (reviewed by Garrod,
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1996). They are restricted to stratified epithelia. Dsg2 is present in
all desmosome-containing tissues, including simple and stratified
epithelia. However, in stratified squamous epithelia Dsg2 is
detected only in the basal cell layer and appears to be absent from
suprabasal strata (Schafer et al, 1996).
Immunohistochemical staining with the antidesmoglein anti-
bodies on normal skin reveals clear, strong pericellular localiza-
tion of the antigen, outlining the cell membranes of the
keratinocytes (Burge and Garrod, 1991). We documented the
differential staining ofKA and SCC forDsgl and Dsg3 in paraffin
sections using 32-2B monoclonal antibody (Krunic et al, 1996).
These markers were reduced or absent in SCC of the skin, but
preserved in keratoacanthoma, correlating with the high differenti-
ation ofthe latter.
We have examined the staining for Dsg using the monoclonal
antibody 33-3D, a mouse IgM monoclonal antibody, that recog-
nizes the cytoplasmic domains of human Dsgl and Dsg2 and can
be used on frozen sections (Vilela et al, 1995; DR Garrod, unpub-
lished observations). The study was designed to determine the
pattern of Dsg staining in AK, KA and SCC and to correlate the
immunohistochemical findings with the clinical, biological and
histopathological features ofthese neoplasms.
MATERIAL AND METHODS
Patients and specimens
Biopsy samples of 12 KAs, 24 SCCs and 30 AKs were obtained
from predominantly sun-exposed sites in 36 patients from the
Dermatologic Surgery Unit, Duke University Medical Center,
Durham, NC, USA. The so-called 'secondary' SCCs arising on
chronic ulcers and sinuses, osteomyelitis, scars, thermal and radia-
tion keratoses, or pre-existing dermatoses were excluded. Each
tumour was excised and then bisected: one-half was processed in
paraffin for routine histopathological diagnosis and the other
subjected to immunohistochemical analysis. Strict clinical and
histological criteria were used to differentiate between KAs, SCCs
and AKs (Fisher et al, 1972; Janecka et al, 1978; Schwartz, 1994;
Schwartz, 1996).
Immunohistochemical staining procedure (Vilela et al,
1987; Burge and Garrod, 1991)
Immunohistochemical staining was completed in approximately
1 h using the following protocol. The sections (5-6 gm) were
mounted on Superfrost plus slides (Fisher Scientific, Pittsburgh,
PA, USA), fixed in acetone for S min and air dried. Next, the
sections were incubated for 30 min with the 33-3D anti-
desmoglein monoclonal antibody (Vilela et al, 1995; Krunic et al,
1996; Schafer et al, 1996), rinsed in phosphate-buffered saline
(PBS) and incubated for 15 min with the secondary biotinylated
anti-mouse IgM. The sections were then rinsed with PBS and incwt-
bated for 5 min with avidin-biotin-peroxidase conjugate, and then
with diaminobenzidine as a chromogen. The slides were then
washed in tap water and counterstained with haematoxylin.
All reagents except the primary antibodies were included in the
Vectastatin Elite ABC mouse kit (Vector Laboratories). Negative
controls that used PBS instead of the various antibodies were
run in parallel, while adjacent, uninvolved epidermis served as a
positive control.
Evaluation of Dsg staining
The sections stained with the anti-desmoglein antibody were
examined independently by three of the authors (AK, REC, SM)
without knowledge of the histological assessment or subsequent
clinical course of the patient. The degree of desmoglein staining
was graded as follows: +++, extensive pericellular staining up
to the tumour-host border; ++, focal pericellular staining; +,juxta-
nuclear staining pattern; 0, no staining.
RESULTS
Keratoacanthomas (n = 12)
Twelve tumours were examined. All sections showed uniform
extensive pericellular staining for Dsg (+++) throughout the non-
keratinized layers ofthe tumour (Figure IA and B). The keratinous
crater as well as the lower surface of the basal cells remained
unstained. Thus, the staining pattern was entirely similar to
the Dsg distribution detected in the normal epidermis and to that
previously found in KAs with monoclonal antibody 32-2B
(Krunic et al, 1996).
Squamous cell carcinomas (n = 24)
Twenty-four tumours of variable differentiation were examined.
All demonstrated significant reduction in Dsg staining. Focalperi-
cellular staining (++) was seen in five SCCs (Figure IC and D),
with complete absence of the desmoglein marker in seven
tumours. The remaining 12 SCCs demonstrated predominantly
juxtanuclear localization ofthe Dsg antigen (+) (Figure 1E). None
of the SCCs studied showed positive staining throughout all
tumour epithelium, in marked contrast to KA.
Actinic keratosis (n = 30)
The most common finding in AKs examined was focally
preserved perimembranous staining for Dsg (++) with absence of
staining indysplastic areas ofnon-keratinized epithelium (Figure IF)
(25 specimens, 11 hypertrophic and 14 atrophic). In the remaining
five cases (Bowenoid AK) absence of pericellular staining in
dysplastic areas was associated with the juxtanuclear localization
of Dsg (+). Fully keratinized layers of the epidermis remained
unstained. None of the AKs demonstrated positive pericellular
localization of Dsg throughout the full thickness of the neoplastic
epithelium.
DISCUSSION
Our results show a clear difference in immunohistochemical
staining forDsg between KAs on the one hand and AKs and SCCs
on the other. These results are entirely consistent with those ofour
previous study ofKAs and SCCs using the anti-desmoglein mono-
clonal antibody on paraffin-embedded material. In both studies the
Dsg antigen was preserved in all KAs as strong pericellular
staining throughout the full thickness of non-keratinized epithe-
lium. The keratinous crater and lower pole of the basal cells
remained unstained. This pattern is entirely similar to one
observed in normal epidermis with these monoclonal antibodies
(Vilela et al, 1987; Burge and Garrod, 1991). The results of
this study are also compatible with the complete retention of
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Figurel 1(A) Keratoacanthoma.Staining extends throughout all non-keratinized epithelium (33-3D x10).(B) Keratoacanthoma,Higher power reveals strong
perimembranous localization of desmolgein marker. Virtually all epithelial cells are uniformly positive (33-31D x 25). (C) Squamous cell carcinoma. Focal loss of
desmoglein expression in dysplastic areas of tumour epithelium (33-31D x 13.2). (D) Squamous cell carcinoma. Pericellular staining for desmoglein is retained
only in well-differentiated areas (33-31D x 33). (E) Squamous cell carcinoma. Juxtanuclear localization of desmoglein marker is associated with the absence of
the perimembranous stain in some areas (arrow) (33-31D x 33). (F) Actinic keratosis. Focal loss of desmoglein marker is present in dysplastic areas. Note that
basal and immediate suprabasal area are negative, where atypical cells are present. Normal 'pericellular' pattern is retained in higher parts of the prickle cell
layer, especially in the immediate subgranular zone, consistent with very differentiated keratinocytes (33-31D x 10)
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pemphigus antigen in KA shown in several indirect immuno-
fluorescent studies (Muller and Flannery, 1973; De Moragas et al,
1970). Absent staining in the regions of keratinized crater is
consistent with advanced keratinization and subsequent reduction
and loss of desmosomes (Vilela et al, 1987; Mils et al, 1992;
Krunic et al, 1996); no staining of the stratum corneum is found
in normal epidermis. The lower poles of basal cells remained
unstained, as they have hemidesmosomes and therefore do not
have Dsg (Garrod, 1993).
By contrast, SCCs demonstrated either focal Dsg staining or
complete absence of this antigen. Partial or total absence of Dsg
marker may be consistent with impaired differentiation as well as
potential for invasion and metastases (Harada et al, 1992; Hiraki et
al, 1996). This is because it may indicate partial or complete loss
of desmosomes, suggesting weakened intercellular adhesion and
easy detachment ofthe cell from the primary site. Thejuxtanuclear
staining for Dsg observed in some SCCs is probably consistent
with internalized desmosomes and also presents an indicator of
reduced intercellular adhesion and possible malignant behaviour
(Ghadially, 1980). This pattern was also constantly absent from all
specimens of KA, and was not detected in normal epidermis
(Ghadially, 1980).
All 30 cases of AK showed focal loss of the Dsg marker in
dysplastic epithelium. The most prominent reduction in Dsg
staining was seen in Bowenoid AK, where few cells retained peri-
cellular staining. Juxtanuclear localization of the Dsg marker was
also prominent in these cases. Thick keratinized layers of hyper-
trophic forms ofAK remained unstained.
Although our results are consistent with the view that AK is a
premalignant condition, another study showed that staining for the
adhesion molecule E-cadherin, a component of adherens junc-
tions, was undiminished compared with the normal epidermis
among a sample of four AKs (Fuller et al, 1996). In the same
study 4 of 16 SCCs showed undiminished staining for E-cadherin
whereas in the remainder staining was reduced or absent.
The Dsg staining that we have found appears consistent with the
results of electron microscopical studies in KAs, in which the
numbers and cell-surface densities of desmosomes have been
found to be normal whereas in SCCs they are reduced (Fisher et al,
1972; Miracco et al, 1992). We are not aware ofany ultrastructural
studies ofdesmosomes in AKs. Our present results are also similar
to our findings for desmosomal staining in oral SCCs and transi-
tional cell carcinoma, in which reduction in staining for Dsg and
other desmosomal components has been found to be associated
with invasive and/or metastatic behaviour (Conn et al, 1990;
Hiraki et al, 1996; Shinohara et al, 1997). They contrast, however,
with our findings for colorectal carcinoma, in which no reduction
in desmosomal staining was detected in association with low
differentiation status or metastasis.
It is pertinent to mention the recent reports ofdistinctive genetic
changes detected by loss ofheterozygosity (LOH) analysis in KAs
(Waring et al, 1996), AKs (Rehman et al, 1994; Rehman et al,
1996) and SCCs (Quinn et al, 1994). These demonstrate similar
patterns ofallelic loss involving chromosome arms 17p, 17q, 13q,
9p in AKs and SCCs including arm 3p in AK and arm 9q in SCC
respectively. Fractional allelic loss (FAL) was as high as 46% in
AKs and around 32% in SCCs. The same authors reported signifi-
cantly lower values for FAL in KAs (Waring et al, 1996) (only
1.3%o), which was limited to 9p, 9q and lOq arms. In addition to
chromosome loss, recent studies disclosed diffuse presence ofbcl-
2 proto-oncogene expression in SCCs consistent with uncontrolled
proliferation in this tumour (Sleater et al, 1994). The same investi-
gation revealed bcl-2 positivity in KAs in the proliferative phase
(Sleater et al, 1994), which was limited to the basal cell area,
similar to normal epidermis or adnexal epithelium (Lu et al, 1993).
In the process of maturation the bcl-2 activity disappears, consis-
tent with the initiation of apoptosis at involution of KAs. Bcl-2
positivity was also detected in hypertrophic AKs and was confined
to the atypical keratinocytes (Nakagawa et al, 1994).
Whatis the significance ofthese observations fordetermining the
relationships between these common neoplasms? The ability to
metastasize, although not an absolute criterion, is generally accepted
as an indicator of malignancy. Retention of desmosomes (Miracco
et al, 1992), low level ofFAL (Waring et al, 1996) as well as loss of
bcl-2 positivity (Sleater et al, 1994) in KA suggests that this
neoplasm is well differentiated and has a controlled predetermined
evolution through the phases ofproliferation, maturation and invo-
lution. We agree with Waring et al (1996) that multiple differences
exist between KAs and SCCs, and that the existence of 'metasta-
sizing KAs' is not absolutely convincing (Krunic et al, 1996). On
the other hand, focal loss of Dsg staining in AKs is similar to that
observed in SCCs (Krunic etal, 1996) and, together with bcl-2 posi-
tivity (Nakagawa et al, 1994) as well as high FAL (Rehman et al,
1994, 1996), underlines the premalignant nature of this neoplasm.
However, this does notexplain the long-term low incidence ofinva-
sive growth and the 20% regression rate observed in this neoplasm
(Marks et al, 1988; Schwartz, 1996). The accumulation of genetic
changes, especially related to UVR, may at some point result in the
emergence ofclonalimmortality and subsequent invasivebehaviour
(Rehman et al, 1994; Rehman et al, 1996; Schwartz et al, 1996).
An interestingpoint is thatchromosome 18, whereDsg genes are
located (Simraketal, 1995), is notfound to be affected in any ofthe
aforementioned genetic studies. We may speculate that products of
othermutated genes may somehow reduce or suppress Dsgproduc-
tion in AKs and SCCs. In some instances this could be the gene for
the desmosomal component plakoglobin, which is located at chro-
mosome 17q21 (Aberle et al, 1995), which is one of the regions
affected in AKs and SCCs. Low FAL on arm 9p (around 1%)
(Waring et al, 1996) found in KAs may beconsistent withpreserva-
tion of Dsg staining and different biological behaviour when full
terminal differentiation follows the phase of rapid growth. This
phase may also be responsible for the exhaustion ofgrowth poten-
tial before progression to clonal immortality occurs (Prehn, 1996).
In conclusion, we believe that immunohistochemical analysis
with 33-3D antibody clearly demonstrates different staining
patterns between KAs and SCCs. Focal loss ofDsg marker seen in
AKs is consistent with its premalignant character. As the stain
works on frozen tissue, it may be helpful for rapid differentiation
in selected cases in cutaneous oncology and Mohs micrographic
surgery. This antibody may also have great potential for the detec-
tion of the effects on chemopreventive agents in skin samples
because the loss of desmosomes may be considered as one of the
earliest events during carcinogenesis.
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